PCV86 PATTERNS OF DIURETIC USE IN MULTI-DRUG ANTI-HYPERTENSIVE REGIMENS IN THE POSTALLHAT ERA  by Parikh, NM et al.
hospitalization and outpatient hospital visit were assessed using
Cox-proportional hazard models. Counts of ofﬁce visits were
assessed using negative binomial regression models. RESULTS:
Elders with a claim for depression had a higher frequency of
inpatient hospitalizations (52.4%) and emergency department
visits (29.7%) than elders without a depression claim (36.4%
and 19.1%). Elders with a depression claim were admitted to the
hospital 51% sooner (95% CI = 1.31, 1.76), visited an emer-
gency department 56% sooner (95% CI = 1.29, 1.90), and had
an outpatient hospital visit 19% sooner (95% CI = 1.03, 1.38)
than elders without a depression claim. A depression claim had
no effect on the number of physician ofﬁce visits. Antidepressant
use by elders with a depression claim was not signiﬁcantly asso-
ciated with health care utilization. CONCLUSION: Elders with
a claim for depression after a TCE use more acute health care
services and sooner than those without a depression claim.
Antidepressant use does not affect this relationship.
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OBJECTIVE: Upon implementation of Medicare Part D in 2006,
Medicaid and Medicare dual-eligibles were shifted to Part D for
their prescription drug coverage. This shift affected the utiliza-
tion and market share of medications under Medicaid. This study
focuses on statins which are widely prescribed. The objectives
were: 1) to describe the number of units dispensed, the number of
prescriptions, and total expenditures for statins in 2005 and
2006, nationally and for each state, and 2) to assess the shift
in market share for these drugs between 2005 and 2006.
METHODS: Summary claims data for 11 commonly prescribed
statins were obtained from the Centers for Medicare and Med-
icaid Services website for all US states for 2005 and 2006. Total
units of statins reimbursed, total number of prescriptions, total
reimbursement amount, and percent market share were calcu-
lated for each of the statins and for each of the 50 states.
RESULTS: The total units of statins reimbursed decreased from
573.5 million in 2005 to 201.0 million in 2006, as did the total
number of prescriptions (17.5 million in 2005 vs. 6.2 million in
2006), and the total reimbursement amount ($1.8 billion in 2005
vs. $0.66 billion in 2006). The percentage market share of
Lipitor® units decreased from 48.7% in 2005 to 42.8% in 2006.
Similar trends were observed for percentages of prescriptions and
reimbursement amounts. Zocor® also showed the same trend
while Vytorin® and generic statin use increased. State wise com-
parisons show variability among states with CA and NY having
the highest statin use. CONCLUSION: Overall, the ﬁndings of
the study indicate a substantial decrease in statin prescriptions
covered by Medicaid for the year 2006. This decrease in utiliza-
tion along with the shift to generic statins affects the rebates
received by Medicaid.
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OBJECTIVE: Our study goal was to determine if the proportion
of “diuretic eligible” patients receiving diuretics, including thi-
azides, for hypertension control in multi-drug antihypertensive
regimens has increased since the publication of ALLHAT and
JNC7. METHODS: We used an electronic medical records
repository of a tertiary care VA Medical Center to determine
medication use in 8286 non-diabetic hypertensives in March
2005. Patients selected did not have contraindications for thiaz-
ides (gout, heart failure, creatinine >=2 mg/dL) and were catego-
rized as receiving one, two, three, or four or more drugs. Diuretic
use overall, for the elderly (age60 years) and African-American
subgroups was compared to March 2001 levels. RESULTS: Rates
of any diuretic use were 27.6%, 56.7%, 78.2% and 90.5% in
people on single, two, three and four or more drugs respectively.
Thiazide use rates were 26.7%, 52.6%, 69.7%, and 77.8% in
those groups, respectively. Comparable rates of thiazide diuretics
utilization from 2001 were 11.6%, 39%, 59%, and 72.5%,
respectively (p < 0.05 for all comparisons). The proportion of
African-American patients on 2, 3, or 4 or more drugs was
67.5%, 84.6% and 91.6% respectively (p < 0.05 for all compari-
sons except 4 or more drugs; p = 0.102). Overall, 49% of the
elderly received diuretics: 22.6% on monotherapy (p < 0.05),
and 49.6%, 75.2% and 91.6% on 2, 3, or 4 or more drugs
(p > 0.05). CONCLUSION: Use of thiazides to treat multidrug
hypertension has increased since release of JNC-7 and ALLHAT,
indicating evidence-based provision of care in the VA. However,
there is still room for improvement and need for additional study
of factors affecting thiazide use in hypertensive patients,
especially the elderly.
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OBJECTIVE: To determine the rate of off-label prescribing of
statins for patients diagnosed with hypertension and/or diabetes
and to identify the patient and physician characteristics affecting
the prescribing of statins. METHODS: Data from the National
Ambulatory Medical Care Survey (NAMCS) for the year 2005
was used. Hypertension and diabetes visits were identiﬁed based
on the ICD-9-CM diagnoses code, reason-for-visit codes, and an
afﬁrmative answer to a question asking whether the patient is
currently suffering from hypertension/diabetes. Statin visits were
identiﬁed using the NAMCS generic drug codes. “On-label”
statin visits deﬁned as visits having ICD-9-CM diagnoses code,
reason-for-visit code for hyperlipidemia, Acute Myocardial Inf-
arction, Ischemic Heart Disease, Angina, & Atherosclerosis,
a CPT-4 code for revascularization, or a lipid lab test were
excluded. Multivariate logistic regression models were applied
using Stata 9 to take into account the complex survey design.
RESULTS: In 2005, 23.1 million diabetes visits (95% CI = 18.3–
28.0 million), and 50.1 million hypertension visits (95%
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